Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • AUXILIUM PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: AUXL

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.200 Buy 15
    30 Days Ago 2.200 Buy 15
    60 Days Ago 2.188 Buy 16
    90 Days Ago 2.000 Buy 15
    120 Days Ago 2.071 Buy 14

  • Analyst Ratings: AUXL

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Deutsche Securities — Buy 09/15/2009 41.00
    Brean Murray — Sell 08/06/2009 15.00
    Caris & Company — Sell 07/20/2009 18.00
    Hapoalim — Outperform 06/25/2009 33.00
    FTN Equity Capital Buy Sell 04/01/2009 —
    RBC Capital Mkts — Sector Perform 03/19/2009 —
    FTN Equity Capital — Buy 03/12/2009 —
    Roth Capital — Hold 02/25/2009 27.00
    Deutsche Securities — Buy 01/20/2009 34.00
    Roth Capital — Hold 12/19/2008 25.00
    Stanford Research — Buy 11/13/2008 28.00
    Leerink Swann — Outperform 11/10/2008 30.00
    Deutsche Securities Hold Buy 11/02/2008 29.00
    Roth Capital Sell Hold 11/02/2008 19.00
    Brean Murray — Sell 09/30/2008 18.00
    Oppenheimer — Outperform 09/11/2008 44.00
    Banc of America Sec Buy Neutral 08/14/2008 —
    Collins Stewart — Buy 08/13/2008 49.00
    Citigroup Buy Hold 07/24/2008 37.00
    Roth Capital — Sell 07/18/2008 32.00
    Merriman Curhan Ford Sell — 06/05/2008 —
    Pacific Growth Equities — Buy 05/15/2008 36.00
    Merriman Curhan Ford Neutral Sell 03/24/2008 —
    Soleil Hold Buy 03/24/2008 34.00
    Deutsche Securities — Hold 02/15/2008 31.00
    Roth Capital — Sell 02/15/2008 22.00
    Jefferies & Co — Buy 01/15/2008 40.00
    Soleil Buy Hold 12/04/2007 —
    Deutsche Securities — Hold 11/01/2007 22.00
    Roth Capital Hold Sell 11/01/2007 16.00
    Next